Future Cardia
Tiny implantable cardiac device using telemedicine and AI
Overview
Raised: $3,114,169
Total Commitments ($USD)
StartEngine
12/21/2021
Not Provided
$250
Equity - Common
Seed
RegA+
$2.00
$20,000,000
Rolling Commitments ($USD)
06/29/2022
$17,301
2,369
2019
Healthcare & Pharmaceuticals
Medtech
B2B2C
Medium
High
Balance Sheet
|
Cash and Cash Equivalents |
$291,682 |
|
Investment Securities |
$0 |
|
Total Investments |
$0 |
|
Accounts and Notes Receivable |
$34,156 |
|
Loans |
$0 |
|
Property, Plant and Equipment (PP&E) |
$0 |
|
Property and Equipment |
$0 |
| Total Assets |
$325,838 |
|
Accounts Payable & Accrued Liabilities |
$4,590 |
|
Policy Liabilities and Accruals |
$0 |
|
Deposits |
$0 |
|
Long Term Debt |
$505,404 |
|
Total Liabilities |
$509,994 |
|
Total Stockholders' Equity |
$-184,156 |
| Total Liabilities and Equity |
$325,838 |
Statement of Comprehensive Income Information
|
Total Revenues |
$0 |
|
Total Interest Income |
$0 |
|
Costs & Expenses Applicable to Rev |
$0 |
|
Total Interest Expenses |
$0 |
|
Depreciation and Amortization |
$0 |
| Net Income |
$-370,847 |
|
Earnings Per Share - Basic |
$-0.04 |
|
Earnings Per Share - Diluted |
$-0.04 |
Raise History
| Offering Name | Close Date | Platform | Valuation/Cap | Total Raised | Security Type | Status | Reg Type |
|---|---|---|---|---|---|---|---|
| Future Cardia | 04/28/2024 | StartEngine | $40,112,855 | $2,982,488 | Equity - Common | Active | RegCF |
| Future Cardia | 06/19/2022 | StartEngine | $20,000,000 | $3,114,169 | Equity - Common | Funded | RegA+ |
| Oracle Health | 08/27/2021 | Republic | $20,000,000 | $3,336,866 | Equity - Common | Funded | RegA+ |
| Oracle Health | 03/22/2020 | Microventures | $5,000,000 | $275,104 | SAFE | Funded | RegCF |
Price per Share History
Note: Share prices shown in earlier rounds may not be indicative of any stock splits.
Valuation History
Revenue History
Note: Revenue data points reflect the latest of either the most recent fiscal year's financials, or updated revenues directly from the founder, at each raise's close date.
Employee History
Upgrade to gain access
-
$25 /month
billed annually - Free portfolio tracking, data-driven ratings, AI analysis and reports
- Plan Includes:
- Everything in Free, plus
- Company specific
KingsCrowd ratings and analyst reports
- Deal explorer and side-by-side comparison
- Startup exit and failure tracking
- Startup market filters and historical industry data
- Advanced company search ( with ratings)
- Get Edge Annual
Edge
Ratings 
Founder Profile
Future Cardia Founder Jaeson Bang Is Preventing Heart Failure
Although COVID-19 has captured the world’s attention over the past few years, heart disease is still the top cause of death in the United States. Heart attacks can occur without the sufferer even noticing, and individuals who survive one heart attack are often at risk of having another. Monitoring a recurring patient’s condition can make the difference between life and death.
Future Cardia is working to keep patients safe with long-term heart-monitoring implants. After a quick and easy insertion, the devices will be able to gather actionable data and predict heart failure ahead of time. We reached out to founder and CEO Jaeson Bang to learn how he met the team and the short- and long-term goals of the company.
Note: This interview was conducted over phone and email. It has been lightly edited for clarity and length.